Genmab A/S (GMAB) is listed on NASDAQ in Pharmaceutical Stocks. It is $33.21, -2.61%. RSI is 63.0, near overbought.
Technical Analysis
RSI (14) 63.0 Near Overbought
Volume 1.4M
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $65.68 | 62.9 | $6.2B |
| | $105.79 | 46.8 | $5.9B |
| | $40.94 | 41.9 | $5.5B |
| | $53.91 | 53.0 | $8.3B |
| | $280.77 | 42.4 | $5.6B |
Take GMAB further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put GMAB in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Genmab A/S next reports.
Set alerts on GMAB
Get notified when Genmab A/S hits your price targets or technical conditions are met.
Get Started Free